To: Judy Doherty

Nevertheless, only a prospective trial that randomly assigned at least 300 people to either (1) a VLFNV diet, (2) an MS diet, or (3) the current Step 2 Diet advocated by the NCEP/AHA could clearly establish which approach is most efficacious for treating high-risk CAD patients with dyslipidemia. ................
................